Ashna Ashneen Khan

Title: Ashna Ashneen Khan: Innovator in Anticancer Therapeutics

Introduction

Ashna Ashneen Khan is a notable inventor based in Auckland, New Zealand. She has made significant contributions to the field of cancer research through her innovative work on DNA methyltransferase inhibitors. Her research focuses on developing therapeutic agents that can potentially revolutionize cancer treatment.

Latest Patents

Ashna holds a patent for "Inhibitors of DNMT1 as anticancer therapeutic agents." This patent describes inhibitors of DNA methyltransferase 1, an enzyme crucial for maintaining DNA CpG methylation marks in human cells. The invention encompasses compounds, pharmaceutical compositions, and methods for inhibiting DNA methyltransferase 1, showcasing her commitment to advancing cancer therapies. She has 1 patent to her name.

Career Highlights

Throughout her career, Ashna has worked with reputable organizations, including Victoria Link Limited and Albert Einstein College of Medicine. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ashna has collaborated with notable colleagues such as Peter Charles Tyler and Farah Lamiable-Oulaidi. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Ashna Ashneen Khan is a pioneering inventor whose work in anticancer therapeutics is making a significant impact in the field of medicine. Her innovative approach to inhibiting DNA methyltransferase 1 holds promise for future cancer treatments.